• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物治疗肺纤维化的潜在疗法。

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis.

机构信息

Department of Biochemistry and Molecular Biology, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Dhaka 8100, Bangladesh.

Department of Oriental Biomedical Engineering, College of Health Sciences, Sangji University, Wonju 26339, Korea.

出版信息

Molecules. 2022 Feb 22;27(5):1481. doi: 10.3390/molecules27051481.

DOI:10.3390/molecules27051481
PMID:35268581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8911636/
Abstract

Pulmonary fibrosis (PF) is a disease-refractive lung condition with an increased rate of mortality. The potential factors causing PF include viral infections, radiation exposure, and toxic airborne chemicals. Idiopathic PF (IPF) is related to pneumonia affecting the elderly and is characterized by recurring scar formation in the lungs. An impaired wound healing process, defined by the dysregulated aggregation of extracellular matrix components, triggers fibrotic scar formation in the lungs. The potential pathogenesis includes oxidative stress, altered cell signaling, inflammation, etc. Nintedanib and pirfenidone have been approved with a conditional endorsement for the management of IPF. In addition, natural product-based treatment strategies have shown promising results in treating PF. In this study, we reviewed the recently published literature and discussed the potential uses of natural products, classified into three types-isolated active compounds, crude extracts of plants, and traditional medicine, consisting of mixtures of different plant products-in treating PF. These natural products are promising in the treatment of PF via inhibiting inflammation, oxidative stress, and endothelial mesenchymal transition, as well as affecting TGF-β-mediated cell signaling, etc. Based on the current review, we have revealed the signaling mechanisms of PF pathogenesis and the potential opportunities offered by natural product-based medicine in treating PF.

摘要

肺纤维化(PF)是一种疾病性肺部疾病,死亡率较高。导致 PF 的潜在因素包括病毒感染、辐射暴露和有毒空气化学物质。特发性 PF(IPF)与影响老年人的肺炎有关,其特征是肺部反复形成疤痕。受损的伤口愈合过程,定义为细胞外基质成分的失调聚集,会引发肺部纤维化疤痕的形成。潜在的发病机制包括氧化应激、细胞信号改变、炎症等。尼达尼布和吡非尼酮已被批准有条件用于 IPF 的治疗。此外,基于天然产物的治疗策略在治疗 PF 方面显示出了有希望的结果。在这项研究中,我们回顾了最近发表的文献,并讨论了天然产物的潜在用途,分为三类:分离的活性化合物、植物的粗提取物和由不同植物产品组成的混合物的传统医学,在治疗 PF 方面。这些天然产物通过抑制炎症、氧化应激和内皮间质转化,以及影响 TGF-β 介导的细胞信号等,在治疗 PF 方面具有广阔的应用前景。基于目前的综述,我们揭示了 PF 发病机制的信号机制以及天然产物药物在治疗 PF 方面提供的潜在机会。

相似文献

1
Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis.天然产物治疗肺纤维化的潜在疗法。
Molecules. 2022 Feb 22;27(5):1481. doi: 10.3390/molecules27051481.
2
Monomeric compounds from natural products for the treatment of pulmonary fibrosis: a review.天然产物中的单体化合物治疗肺纤维化:综述。
Inflammopharmacology. 2024 Aug;32(4):2203-2217. doi: 10.1007/s10787-024-01485-0. Epub 2024 May 9.
3
The efficacy of plant extract and bioactive compounds approaches in the treatment of pulmonary fibrosis: A systematic review.植物提取物和生物活性化合物方法在肺纤维化治疗中的疗效:系统评价。
Biomed Pharmacother. 2017 Sep;93:666-673. doi: 10.1016/j.biopha.2017.06.052. Epub 2017 Jul 5.
4
Effects of Natural Products through Inhibiting Endoplasmic Reticulum Stress on Attenuation of Idiopathic Pulmonary Fibrosis.天然产物通过抑制内质网应激对特发性肺纤维化衰减作用的影响。
Drug Des Devel Ther. 2024 May 17;18:1627-1650. doi: 10.2147/DDDT.S388920. eCollection 2024.
5
Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.特发性肺纤维化患者经吡非尼酮或尼达尼布治疗后的肺组织的组织病理学和分子分析。
Histopathology. 2019 Jan;74(2):341-349. doi: 10.1111/his.13745. Epub 2018 Nov 11.
6
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis.抗纤维化药物尼达尼布和吡非尼酮治疗特发性肺纤维化(IPF)和非特发性肺纤维化(非 IPF)进展性肺纤维化的疗效:系统评价和荟萃分析。
BMC Pulm Med. 2021 Dec 11;21(1):411. doi: 10.1186/s12890-021-01783-1.
7
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.抗纤维化疗法治疗特发性肺纤维化以外的肺纤维化疾病。
Eur Respir Rev. 2019 Oct 1;28(153). doi: 10.1183/16000617.0022-2019. Print 2019 Sep 30.
8
Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.染料木黄酮通过抑制 TGF-β 介导体外和体内系统中的 EMT、肌成纤维细胞分化和胶原沉积来改善肺纤维化。
Phytomedicine. 2020 Nov;78:153298. doi: 10.1016/j.phymed.2020.153298. Epub 2020 Aug 1.
9
Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization.含羞草提取物通过调节 MAPK 信号通路和 FOXO3 稳定来改善肺纤维化。
J Ethnopharmacol. 2024 Aug 10;330:118226. doi: 10.1016/j.jep.2024.118226. Epub 2024 Apr 25.
10
Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis.尼达尼布可调节博来霉素处理的大鼠和肺纤维化患者的活肺组织切片中 III 型胶原蛋白的转化。
Respir Res. 2022 Aug 4;23(1):201. doi: 10.1186/s12931-022-02116-4.

引用本文的文献

1
The impact of para-hydroxycinnamic acid on myofibroblast trans-differentiation in MRC-5 and A549 cell lines: in silico and in vitro evaluation.对羟基肉桂酸对MRC - 5和A549细胞系中成肌纤维细胞转分化的影响:计算机模拟和体外评估
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 19. doi: 10.1007/s00210-025-04524-x.
2
Causal Association Between 12 Micronutrients and Common Chronic Respiratory Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.12种微量营养素与常见慢性呼吸道疾病之间的因果关联:一项双向双样本孟德尔随机化研究
Genet Res (Camb). 2025 May 28;2025:7575005. doi: 10.1155/genr/7575005. eCollection 2025.
3

本文引用的文献

1
antioxidant and wound healing properties of baru nut extract ( Vog.) in pulmonary epithelial cells for therapeutic application in chronic pulmonary obstructive disease (COPD).巴鲁果提取物(Vog.)的抗氧化和伤口愈合特性在肺上皮细胞中的治疗应用于慢性阻塞性肺疾病(COPD)。
Nat Prod Res. 2022 Sep;36(17):4475-4481. doi: 10.1080/14786419.2021.1984909. Epub 2021 Oct 7.
2
Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management.特发性肺纤维化的肺部以外表现:了解疾病机制以改善诊断和管理。
Respir Res. 2021 Apr 17;22(1):109. doi: 10.1186/s12931-021-01711-1.
3
The role of natural products in the prevention and treatment of pulmonary fibrosis: a review.
Triptolide Ameliorates Collagen-Induced Arthritis and Bleomycin-Induced Pulmonary Fibrosis in Rats by Suppressing IGF1-Mediated Epithelial Mesenchymal Transition.
雷公藤甲素通过抑制胰岛素样生长因子1介导的上皮-间质转化改善大鼠胶原诱导的关节炎和博来霉素诱导的肺纤维化。
Chin J Integr Med. 2025 May 26. doi: 10.1007/s11655-025-4224-z.
4
Traditional Herbal Plants and their Phytoconstituents Based Remedies for Respiratory Diseases: A Review.基于传统草药植物及其植物成分的呼吸系统疾病治疗方法综述
Open Respir Med J. 2025 Feb 12;19:e18743064341009. doi: 10.2174/0118743064341009241210045737. eCollection 2025.
5
Interactions of flavonoid and coumarin derivative compounds with transforming growth factor-beta receptor 1 (TGF-βR1): integrating virtual screening, molecular dynamics, maximum common substructure, and ADMET approaches in the treatment of idiopathic pulmonary fibrosis.类黄酮和香豆素衍生物化合物与转化生长因子-β受体1(TGF-βR1)的相互作用:在特发性肺纤维化治疗中整合虚拟筛选、分子动力学、最大公共子结构和ADMET方法
J Mol Model. 2025 Mar 24;31(4):124. doi: 10.1007/s00894-025-06338-3.
6
Recent Advances in the Mechanisms of Postoperative Neurocognitive Dysfunction: A Narrative Review.术后神经认知功能障碍机制的最新进展:一篇叙述性综述
Biomedicines. 2025 Jan 7;13(1):115. doi: 10.3390/biomedicines13010115.
7
A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived miRNAs.植物疗法的新前沿:利用药用植物衍生 miRNA 的治疗潜力。
Curr Pharm Des. 2024;30(38):3009-3017. doi: 10.2174/0113816128310724240730072626.
8
Effect of Fruit Hydroalcoholic Extract on Paraquat-Induced Pulmonary Fibrosis in the Rat.水果水醇提取物对百草枯诱导的大鼠肺纤维化的影响。
Int J Mol Cell Med. 2023;12(4):423-434. doi: 10.22088/IJMCM.BUMS.12.4.423.
9
Vinpocetine alleviated alveolar epithelial cells injury in experimental pulmonary fibrosis by targeting PPAR-γ/NLRP3/NF-κB and TGF-β1/Smad2/3 pathways.长春西汀通过靶向 PPAR-γ/NLRP3/NF-κB 和 TGF-β1/Smad2/3 通路减轻实验性肺纤维化中肺泡上皮细胞损伤。
Sci Rep. 2024 May 15;14(1):11131. doi: 10.1038/s41598-024-61269-y.
10
Monomeric compounds from natural products for the treatment of pulmonary fibrosis: a review.天然产物中的单体化合物治疗肺纤维化:综述。
Inflammopharmacology. 2024 Aug;32(4):2203-2217. doi: 10.1007/s10787-024-01485-0. Epub 2024 May 9.
天然产物在肺纤维化的预防和治疗中的作用:综述。
Food Funct. 2021 Feb 15;12(3):990-1007. doi: 10.1039/d0fo03001e.
4
Modified Maimendong decoction in the treatment of patients with idiopathic pulmonary fibrosis: Study protocol for a randomized controlled trial.加味麦冬汤治疗特发性肺纤维化患者:一项随机对照试验的研究方案
Medicine (Baltimore). 2020 Dec 4;99(49):e23460. doi: 10.1097/MD.0000000000023460.
5
Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms.肺部毒物与纤维化:先天与适应性免疫机制。
Toxicol Appl Pharmacol. 2020 Dec 15;409:115272. doi: 10.1016/j.taap.2020.115272. Epub 2020 Oct 5.
6
Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway.甘肃蚤缀通过激活 Nrf2 通路和抑制 NF-κB/TGF-β1/Smad2/3 通路减轻小鼠肺纤维化。
Phytother Res. 2021 Feb;35(2):974-986. doi: 10.1002/ptr.6857. Epub 2020 Sep 30.
7
Attenuation of Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats by Combination Treatment of Two Natural Phenolic Compounds: Quercetin and Gallic Acid.两种天然酚类化合物槲皮素和没食子酸联合治疗减轻博来霉素诱导的Wistar大鼠肺纤维化
Nutr Cancer. 2021;73(10):2039-2049. doi: 10.1080/01635581.2020.1820053. Epub 2020 Sep 16.
8
Galangin ameliorated pulmonary fibrosis in vivo and in vitro by regulating epithelial-mesenchymal transition.姜黄素通过调节上皮间质转化改善体内外肺纤维化。
Bioorg Med Chem. 2020 Oct 1;28(19):115663. doi: 10.1016/j.bmc.2020.115663. Epub 2020 Jul 28.
9
Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies.新冠康复者的肺纤维化:预测因素及风险降低策略
Pulm Med. 2020 Aug 10;2020:6175964. doi: 10.1155/2020/6175964. eCollection 2020.
10
Scutellarein inhibits BLM-mediated pulmonary fibrosis by affecting fibroblast differentiation, proliferation, and apoptosis.野黄芩苷通过影响成纤维细胞的分化、增殖和凋亡来抑制博来霉素介导的肺纤维化。
Ther Adv Chronic Dis. 2020 Jul 30;11:2040622320940185. doi: 10.1177/2040622320940185. eCollection 2020.